Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 3:7:1184.
doi: 10.12688/f1000research.15512.3. eCollection 2018.

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort

Waqas Amin  1 , Faina Linkov  2 , Douglas P Landsittel  1 , Jonathan C Silverstein  1 , Wiam Bashara  3 , Carmelo Gaudioso  3   4 , Michael D Feldman  5 , Harvey I Pass  6 , Jonathan Melamed  7 , Joseph S Friedberg  8 , Michael J Becich  1
Affiliations

Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort

Waqas Amin et al. F1000Res. .

Abstract

Background: Malignant mesothelioma (MM) is a rare but deadly malignancy with about 3,000 new cases being diagnosed each year in the US. Very few studies have been performed to analyze factors associated with mesothelioma survival, especially for peritoneal presentation. The overarching aim of this study is to examine survival of the cohort of patients with malignant mesothelioma enrolled in the National Mesothelioma Virtual Bank (NMVB). Methods: 888 cases of pleural and peritoneal mesothelioma cases were selected from the NMVB database, which houses data and associated biospecimens for over 1400 cases that were diagnosed from 1990 to 2017. Kaplan Meier's method was performed for survival analysis. The association between prognostic factors and survival was estimated using Cox Hazard Regression method and using R software for analysis. Results: The median overall survival (OS) rate of all MM patients, including pleural and peritoneal mesothelioma cases is 15 months (14 months for pleural and 31 months for peritoneal). Significant prognostic factors associated with improved survival of malignant mesothelioma cases in this NMVB cohort were younger than 45, female gender, epithelioid histological subtype, stage I, peritoneal occurrence, and having combination treatment of surgical therapy with chemotherapy. Combined surgical and chemotherapy treatment was associated with improved survival of 23 months in comparison to single line therapies. Conclusions: There has not been improvement in the overall survival for patients with malignant mesothelioma over many years with current available treatment options. Our findings show that combined surgical and chemotherapy treatment in peritoneal mesothelioma is associated with improved survival compared to local therapy alone.

Keywords: Biobanking; Mesothelioma; Risk factor; Survival analysis. Cox hazard regression analysis.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Study workflow and case inclusion and exclusion criteria.
Figure 2.
Figure 2.
Kaplan Meier Curve analysis performed at age ( a), gender ( b), anatomic site ( c), histology subtype ( d), history of asbestoses exposure ( e), staging (pleural mesothelioma) ( f), therapy type ( g), and history of smoking ( h).
Figure 3.
Figure 3.. Adjusted Cox Hazard analysis, predictors of mesothelioma survival, multivariable analysis (n=477).
See this image and copyright information in PMC

References

    1. Lanphear BP, Buncher CR: Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992;34(7):718–21. - PubMed
    1. Selikoff IJ, Hammond EC, Seidman H: Latency of asbestos disease among insulation workers in the United States and Canada. Cancer. 1980;46(12):2736–40. 10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L - DOI - PubMed
    1. Eiseman E, Bloom G, Brower J, et al. : Case studies of existing human tissue repositories: "Best Practice" for a biospecimen resource for the genomic and proteomic era.Santa Monica, CA: RAND;2003. Reference Source
    1. Yang H, Testa JR, Carbone M: Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol. 2008;9(2–3):147–57. 10.1007/s11864-008-0067-z - DOI - PMC - PubMed
    1. Price B, Ware A: Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39(7):576–88. 10.1080/10408440903044928 - DOI - PubMed

Publication types